Skip to main content
Erschienen in: World Journal of Urology 11/2020

20.01.2020 | Original Article

A treatment strategy to help select patients who may not need secondary intervention to remove symptomatic ureteral stones after previous stenting

verfasst von: Elena Stojkova Gafner, Thomas Grüter, Marc A. Furrer, Piet Bosshard, Bernhard Kiss, Mihai D. Vartolomei, Beat Roth

Erschienen in: World Journal of Urology | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed at evaluating whether removal of the ureteral stent the day before scheduled secondary intervention facilitates spontaneous ureteral stone passage and thus can spare the pre-stented patient this surgery.

Methods

Retrospective analysis of a single-centre consecutive series of 216 patients after previous stenting due to a symptomatic ureteral stone from 01/2013 to 01/2018. Indwelling stents were removed under local anaesthesia. Patients were told to filter their urine overnight. Multivariate analysis was performed to assess predictive factors for spontaneous stone passage.

Results

34% (74/216) of patients had spontaneous stone passage while the stent was indwelling. Of the remaining 142 patients, 41% (58/142) had spontaneous stone passage within 24 h after stent removal. Only 84/216 (39%) patients needed secondary intervention. Multivariate logistic regression analysis of all 216 patients showed a significant association between spontaneous stone passage and smaller stone size (p < 0.001), distal stone location (p = 0.046) and stent dwell time (p = 0.02). Predictive factors for spontaneous stone passage after stent removal were smaller size (p < 0.001), distal location (p = 0.001), and stone movement while the stent was indwelling (p = 0.016). A treatment strategy was established that helps select patients suitable for conservative management.

Conclusions

The majority (61%) of ureteral stones passed spontaneously after pre-stenting; 34% while the stent was indwelling, 27% within 24 h after stent removal. Besides distal stone location, stone size (< 6 mm) and stone movement (≥ 5 cm) while the stent is indwelling indicate patients who are likely to pass their ureteral stone spontaneously after stent removal. The treatment strategy (decision tree) presented here helps identify those patients.
Literatur
1.
Zurück zum Zitat Scales CD Jr, Smith AC, Hanley JM, Saigal CS (2012) Urologic diseases in America project. Prevalence of kidney stones in the United States. Eur Urol 62:160–165CrossRef Scales CD Jr, Smith AC, Hanley JM, Saigal CS (2012) Urologic diseases in America project. Prevalence of kidney stones in the United States. Eur Urol 62:160–165CrossRef
2.
Zurück zum Zitat Parks JH, Coe FL (1994) An increasing number of calcium oxalate stone events worsens treatment outcome. Kidney Int 45:1722–1730CrossRef Parks JH, Coe FL (1994) An increasing number of calcium oxalate stone events worsens treatment outcome. Kidney Int 45:1722–1730CrossRef
3.
Zurück zum Zitat Skolarikos A, Laguna MP, Alivizatos G, Kural AR, de la Rosette JJ (2010) The role for active monitoring in urinary stones: a systematic review. J Endourol 24:923–930CrossRef Skolarikos A, Laguna MP, Alivizatos G, Kural AR, de la Rosette JJ (2010) The role for active monitoring in urinary stones: a systematic review. J Endourol 24:923–930CrossRef
4.
Zurück zum Zitat Bader MJ, Eisner B, Porpiglia F, Preminger GM, Tiselius H-G (2012) Contemporary management of ureteral stones. Eur Urol 61:764–772CrossRef Bader MJ, Eisner B, Porpiglia F, Preminger GM, Tiselius H-G (2012) Contemporary management of ureteral stones. Eur Urol 61:764–772CrossRef
6.
Zurück zum Zitat Assimos D, Crisci A, Culkin D et al (2016) Preoperative JJ stent placement in ureteric and renal stone treatment: results from the Clinical Research Office of Endourological Society (CROES) ureteroscopy (URS) Global Study. BJU Int 117:648–654CrossRef Assimos D, Crisci A, Culkin D et al (2016) Preoperative JJ stent placement in ureteric and renal stone treatment: results from the Clinical Research Office of Endourological Society (CROES) ureteroscopy (URS) Global Study. BJU Int 117:648–654CrossRef
7.
Zurück zum Zitat Jessen JP, Breda A, Brehmer M et al (2016) International collaboration in endourology: multicenter evaluation of prestenting for ureterorenoscopy. J Endourol 30:268–273CrossRef Jessen JP, Breda A, Brehmer M et al (2016) International collaboration in endourology: multicenter evaluation of prestenting for ureterorenoscopy. J Endourol 30:268–273CrossRef
8.
Zurück zum Zitat Jones BJ, Ryan PC, Lyons O, Grainger R, McDermott TE, Butler MR (1990) Use of the double pigtail stent in stone retrieval following unsuccessful ureteroscopy. Br J Urol 66:254–256CrossRef Jones BJ, Ryan PC, Lyons O, Grainger R, McDermott TE, Butler MR (1990) Use of the double pigtail stent in stone retrieval following unsuccessful ureteroscopy. Br J Urol 66:254–256CrossRef
9.
Zurück zum Zitat Lennon GM, Thornhill JA, Grainger R, McDermott TE, Butler MR (1997) Double pigtail ureteric stent versus percutaneous nephrostomy: effects on stone transit and ureteric motility. Eur Urol 31:24–29CrossRef Lennon GM, Thornhill JA, Grainger R, McDermott TE, Butler MR (1997) Double pigtail ureteric stent versus percutaneous nephrostomy: effects on stone transit and ureteric motility. Eur Urol 31:24–29CrossRef
10.
Zurück zum Zitat Baumgarten L, Desai A, Shipman S et al (2017) Spontaneous passage of ureteral stones in patients with indwelling ureteral stents. Can J Urol 24:9024–9029 Baumgarten L, Desai A, Shipman S et al (2017) Spontaneous passage of ureteral stones in patients with indwelling ureteral stents. Can J Urol 24:9024–9029
11.
Zurück zum Zitat Millman S, Strauss AL, Parks JH, Coe FL (1982) Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis. Kidney Int 22:366–370CrossRef Millman S, Strauss AL, Parks JH, Coe FL (1982) Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis. Kidney Int 22:366–370CrossRef
12.
Zurück zum Zitat Nakada SY, Hoff DG, Attai S, Heisey D, Blankenbaker D, Pozniak M (2000) Determination of stone composition by noncontrast spiral computed tomography in the clinical setting. Urology 55:816–819CrossRef Nakada SY, Hoff DG, Attai S, Heisey D, Blankenbaker D, Pozniak M (2000) Determination of stone composition by noncontrast spiral computed tomography in the clinical setting. Urology 55:816–819CrossRef
14.
Zurück zum Zitat Venkatesh R, Landman J, Minor SD et al (2005) Impact of a double-pigtail stent on ureteral peristalsis in the porcine model: initial studies using a novel implantable magnetic sensor. J Endourol 19:170–176CrossRef Venkatesh R, Landman J, Minor SD et al (2005) Impact of a double-pigtail stent on ureteral peristalsis in the porcine model: initial studies using a novel implantable magnetic sensor. J Endourol 19:170–176CrossRef
15.
Zurück zum Zitat Ryan PC, Lennon GM, McLean PA, Fitzpatrick JM (1994) The effects of acute and chronic JJ stent placement on upper urinary tract motility and calculus transit. Br J Urol 74:434–439CrossRef Ryan PC, Lennon GM, McLean PA, Fitzpatrick JM (1994) The effects of acute and chronic JJ stent placement on upper urinary tract motility and calculus transit. Br J Urol 74:434–439CrossRef
16.
Zurück zum Zitat Taha DE, Elshal AM, Zahran MH, Harraz AM, El-Nahas AR, Shokeir AA (2015) After urgent drainage of an obstructed kidney by internal ureteric stenting: is ureteroscopic stone extraction always needed? Arab J Urol 13:258–263CrossRef Taha DE, Elshal AM, Zahran MH, Harraz AM, El-Nahas AR, Shokeir AA (2015) After urgent drainage of an obstructed kidney by internal ureteric stenting: is ureteroscopic stone extraction always needed? Arab J Urol 13:258–263CrossRef
17.
Zurück zum Zitat Türk C, Knoll T, Seitz C, Skolarikos A, Chapple C, McClinton S (2017) European Association of Urology. Medical expulsive therapy for ureterolithiasis: the EAU recommendations in 2016. Eur Urol 71:504–507CrossRef Türk C, Knoll T, Seitz C, Skolarikos A, Chapple C, McClinton S (2017) European Association of Urology. Medical expulsive therapy for ureterolithiasis: the EAU recommendations in 2016. Eur Urol 71:504–507CrossRef
18.
Zurück zum Zitat Loftus C, Nyame Y, Hinck B et al (2016) Medical expulsive therapy is underused for the management of renal colic in the emergency setting. J Urol 195:987–991CrossRef Loftus C, Nyame Y, Hinck B et al (2016) Medical expulsive therapy is underused for the management of renal colic in the emergency setting. J Urol 195:987–991CrossRef
19.
Zurück zum Zitat Davenport K, Timoney AG, Keeley FX (2006) A comparative in vitro study to determine the beneficial effect of calcium-channel and alpha(1)-adrenoceptor antagonism on human ureteric activity. BJU Int 98:651–655CrossRef Davenport K, Timoney AG, Keeley FX (2006) A comparative in vitro study to determine the beneficial effect of calcium-channel and alpha(1)-adrenoceptor antagonism on human ureteric activity. BJU Int 98:651–655CrossRef
20.
Zurück zum Zitat Moradi M, Abdi H, Ebrahimi S, Rezaee H, Kaseb K (2017) Effects of Tamsulosin and Tolterodine on double J stent-related symptoms: a double-blind, randomized, placebo-controlled trial. SAGE Open Med 5:2050312117696436CrossRef Moradi M, Abdi H, Ebrahimi S, Rezaee H, Kaseb K (2017) Effects of Tamsulosin and Tolterodine on double J stent-related symptoms: a double-blind, randomized, placebo-controlled trial. SAGE Open Med 5:2050312117696436CrossRef
21.
Zurück zum Zitat Pais VM Jr, Smith RE, Stedina EA, Rissman CM (2016) Does omission of ureteral stents increase risk of unplanned return visit? A systematic review and meta-analysis. J Urol 196:1458–1466CrossRef Pais VM Jr, Smith RE, Stedina EA, Rissman CM (2016) Does omission of ureteral stents increase risk of unplanned return visit? A systematic review and meta-analysis. J Urol 196:1458–1466CrossRef
22.
Zurück zum Zitat Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG, Barry MJ (2003) Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 169:1065–1069CrossRef Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG, Barry MJ (2003) Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 169:1065–1069CrossRef
23.
Zurück zum Zitat Lee C, Kuskowski M, Premoli J, Skemp N, Monga M (2005) Randomized evaluation of ureteral stents using validated symptom questionnaire. J Endourol 19:990–993CrossRef Lee C, Kuskowski M, Premoli J, Skemp N, Monga M (2005) Randomized evaluation of ureteral stents using validated symptom questionnaire. J Endourol 19:990–993CrossRef
Metadaten
Titel
A treatment strategy to help select patients who may not need secondary intervention to remove symptomatic ureteral stones after previous stenting
verfasst von
Elena Stojkova Gafner
Thomas Grüter
Marc A. Furrer
Piet Bosshard
Bernhard Kiss
Mihai D. Vartolomei
Beat Roth
Publikationsdatum
20.01.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 11/2020
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-020-03087-1

Weitere Artikel der Ausgabe 11/2020

World Journal of Urology 11/2020 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.